Skip to main content
Top
Published in: Journal of Clinical Immunology 2/2016

01-02-2016 | Original Article

Novel Vasoregulatory Aspects of Hereditary Angioedema: the Role of Arginine Vasopressin, Adrenomedullin and Endothelin-1

Authors: Erika Kajdácsi, Péter K. Jani, Dorottya Csuka, Lilian Varga, Zoltán Prohászka, Henriette Farkas, László Cervenak

Published in: Journal of Clinical Immunology | Issue 2/2016

Login to get access

Abstract

The elevation of bradykinin (BK) level during attacks of hereditary angioedema due to C1-Inhibitor deficiency (C1-INH-HAE) is well known. We previously demonstrated that endothelin-1 (ET-1) level also increases during C1-INH-HAE attacks. Although BK and ET-1 are both potent vasoactive peptides, the vasoregulatory aspect of the pathomechanism of C1-INH-HAE has not yet been investigated. Hence we studied the levels of vasoactive peptides in controls and in C1-INH-HAE patients, as well as evaluated their changes during C1-INH-HAE attacks. The levels of arginine vasopressin (AVP), adrenomedullin (ADM) and ET-1 were measured in the plasma of 100 C1-INH-HAE patients in inter-attack periods and of 111 control subjects, using BRAHMS Kryptor technologies. In 18 of the 100 C1-INH-HAE patients, the levels of vasoactive peptides were compared in blood samples obtained during attacks, or in inter-attack periods. AVP, ADM and ET-1 levels were similar in inter-attack samples from C1-INH-HAE patients and in the samples of controls, although cardiovascular risk has an effect on the levels of vasoactive peptides in both groups. The levels of all three vasoactive peptides increased during C1-INH-HAE attacks. Moreover, the levels of ET-1 and ADM as well as their changes during attacks were significantly correlated. This study demonstrated that vascular regulation by vasoactive peptides is affected during C1-INH-HAE attacks. Our results suggest that the cooperation of several vasoactive peptides may be necessary to counterbalance the actions of excess BK, and to terminate the attacks. This may reveal a novel pathophysiological aspect of C1-INH-HAE.
Literature
1.
go back to reference Bossi F, Fischetti F, Regoli D, Durigutto P, Frossi B, Gobeil Jr F, et al. Novel pathogenic mechanism and therapeutic approaches to angioedema associated with C1 inhibitor deficiency. J Allergy Clin Immunol. 2009;124(6):1303–10.e4. doi:10.1016/j.jaci.2009.08.007. Bossi F, Fischetti F, Regoli D, Durigutto P, Frossi B, Gobeil Jr F, et al. Novel pathogenic mechanism and therapeutic approaches to angioedema associated with C1 inhibitor deficiency. J Allergy Clin Immunol. 2009;124(6):1303–10.e4. doi:10.​1016/​j.​jaci.​2009.​08.​007.
3.
go back to reference Lortie M, Regoli D, Rhaleb NE, Plante GE. The role of B1- and B2-kinin receptors in the renal tubular and hemodynamic response to bradykinin. Am J Phys. 1992;262(1 Pt 2):R72–6. Lortie M, Regoli D, Rhaleb NE, Plante GE. The role of B1- and B2-kinin receptors in the renal tubular and hemodynamic response to bradykinin. Am J Phys. 1992;262(1 Pt 2):R72–6.
5.
go back to reference Davenport AP, Maguire JJ. Endothelin. Handb Exp Pharmacol. 2006;(176 Pt 1):295–329. Davenport AP, Maguire JJ. Endothelin. Handb Exp Pharmacol. 2006;(176 Pt 1):295–329.
7.
go back to reference Eto T, Kato J, Kitamura K. Regulation of production and secretion of adrenomedullin in the cardiovascular system. Regul Pept. 2003;112(1–3):61–9.CrossRefPubMed Eto T, Kato J, Kitamura K. Regulation of production and secretion of adrenomedullin in the cardiovascular system. Regul Pept. 2003;112(1–3):61–9.CrossRefPubMed
8.
go back to reference Kuwasako K, Kida O, Kitamura K, Kato J, Eto T. Plasma adrenomedullin in cerebrovascular disease: a possible indicator of endothelial injury. Int Angiol. 1997;16(4):272–9.PubMed Kuwasako K, Kida O, Kitamura K, Kato J, Eto T. Plasma adrenomedullin in cerebrovascular disease: a possible indicator of endothelial injury. Int Angiol. 1997;16(4):272–9.PubMed
10.
go back to reference Caldwell HK, Young WSI. Oxytocin and vasopressin: genetics and behavioral implications. 3rd ed. handbook of neurichemistry and molecular neurobiology: neuractive proteins and peptides. Berlin: Springer; 2006. Caldwell HK, Young WSI. Oxytocin and vasopressin: genetics and behavioral implications. 3rd ed. handbook of neurichemistry and molecular neurobiology: neuractive proteins and peptides. Berlin: Springer; 2006.
12.
go back to reference Czucz J, Schaffer G, Csuka D, Walentin S, Kunde J, Prohaszka Z, et al. Endothelial cell function in patients with hereditary angioedema: elevated soluble E-selectin level during inter-attack periods. J Clin Immunol. 2012;32(1):61–9. doi:10.1007/s10875-011-9606-7.CrossRefPubMed Czucz J, Schaffer G, Csuka D, Walentin S, Kunde J, Prohaszka Z, et al. Endothelial cell function in patients with hereditary angioedema: elevated soluble E-selectin level during inter-attack periods. J Clin Immunol. 2012;32(1):61–9. doi:10.​1007/​s10875-011-9606-7.CrossRefPubMed
17.
go back to reference Flegal KM, Kit BK, Orpana H, Graubard BI. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. J Am Med Assoc. 2013;309(1):71–82. doi:10.1001/jama.2012.113905.CrossRef Flegal KM, Kit BK, Orpana H, Graubard BI. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. J Am Med Assoc. 2013;309(1):71–82. doi:10.​1001/​jama.​2012.​113905.CrossRef
18.
go back to reference Cnaan A, Laird NM, Slasor P. Using the general linear mixed model to analyse unbalanced repeated measures and longitudinal data. Stat Med. 1997;16(20):2349–80.CrossRefPubMed Cnaan A, Laird NM, Slasor P. Using the general linear mixed model to analyse unbalanced repeated measures and longitudinal data. Stat Med. 1997;16(20):2349–80.CrossRefPubMed
21.
go back to reference Bouillet L, Mannic T, Arboleas M, Subileau M, Massot C, Drouet C, et al. Hereditary angioedema: key role for kallikrein and bradykinin in vascular endothelial-cadherin cleavage and edema formation. J Allergy Clin Immunol. 2011;128(1):232–4. doi:10.1016/j.jaci.2011.02.017.CrossRefPubMed Bouillet L, Mannic T, Arboleas M, Subileau M, Massot C, Drouet C, et al. Hereditary angioedema: key role for kallikrein and bradykinin in vascular endothelial-cadherin cleavage and edema formation. J Allergy Clin Immunol. 2011;128(1):232–4. doi:10.​1016/​j.​jaci.​2011.​02.​017.CrossRefPubMed
25.
go back to reference Vila G, Riedl M, Maier C, Struck J, Morgenthaler NG, Handisurya A, et al. Plasma MR-proADM correlates to BMI and decreases in relation to leptin after gastric bypass surgery. Obesity (Silver Spring). 2009;17(6):1184–8. doi:10.1038/oby.2009.22. Vila G, Riedl M, Maier C, Struck J, Morgenthaler NG, Handisurya A, et al. Plasma MR-proADM correlates to BMI and decreases in relation to leptin after gastric bypass surgery. Obesity (Silver Spring). 2009;17(6):1184–8. doi:10.​1038/​oby.​2009.​22.
27.
go back to reference Kato J, Kitamura K, Uemura T, Kuwasako K, Kita T, Kangawa K, et al. Plasma levels of adrenomedullin and atrial and brain natriuretic peptides in the general population: their relations to age and pulse pressure. Hypertens Res. 2002;25(6):887–92.CrossRefPubMed Kato J, Kitamura K, Uemura T, Kuwasako K, Kita T, Kangawa K, et al. Plasma levels of adrenomedullin and atrial and brain natriuretic peptides in the general population: their relations to age and pulse pressure. Hypertens Res. 2002;25(6):887–92.CrossRefPubMed
28.
go back to reference Wang TJ, Larson MG, Levy D, Leip EP, Benjamin EJ, Wilson PW, et al. Impact of age and sex on plasma natriuretic peptide levels in healthy adults. Am J Cardiol. 2002;90(3):254–8.CrossRefPubMed Wang TJ, Larson MG, Levy D, Leip EP, Benjamin EJ, Wilson PW, et al. Impact of age and sex on plasma natriuretic peptide levels in healthy adults. Am J Cardiol. 2002;90(3):254–8.CrossRefPubMed
31.
go back to reference Nishida H, Horio T, Suzuki Y, Iwashima Y, Kamide K, Kangawa K, et al. Plasma adrenomedullin as an independent predictor of future cardiovascular events in high-risk patients: comparison with C-reactive protein and adiponectin. Peptides. 2008;29(4):599–605. doi:10.1016/j.peptides.2007.12.006.CrossRefPubMed Nishida H, Horio T, Suzuki Y, Iwashima Y, Kamide K, Kangawa K, et al. Plasma adrenomedullin as an independent predictor of future cardiovascular events in high-risk patients: comparison with C-reactive protein and adiponectin. Peptides. 2008;29(4):599–605. doi:10.​1016/​j.​peptides.​2007.​12.​006.CrossRefPubMed
32.
go back to reference Polderman KH, Stehouwer CD, van Kamp GJ, Dekker GA, Verheugt FW, Gooren LJ. Influence of sex hormones on plasma endothelin levels. Ann Intern Med. 1993;118(6):429–32.CrossRefPubMed Polderman KH, Stehouwer CD, van Kamp GJ, Dekker GA, Verheugt FW, Gooren LJ. Influence of sex hormones on plasma endothelin levels. Ann Intern Med. 1993;118(6):429–32.CrossRefPubMed
35.
go back to reference Bolignano D, Cabassi A, Fiaccadori E, Ghigo E, Pasquali R, Peracino A, et al. Copeptin (CTproAVP), a new tool for understanding the role of vasopressin in pathophysiology. Clin Chem Lab Med. 2014;52(10):1447–56. doi:10.1515/cclm-2014-0379.CrossRefPubMed Bolignano D, Cabassi A, Fiaccadori E, Ghigo E, Pasquali R, Peracino A, et al. Copeptin (CTproAVP), a new tool for understanding the role of vasopressin in pathophysiology. Clin Chem Lab Med. 2014;52(10):1447–56. doi:10.​1515/​cclm-2014-0379.CrossRefPubMed
36.
go back to reference Kruger S, Ewig S, Giersdorf S, Hartmann O, Frechen D, Rohde G, et al. Dysnatremia, vasopressin, atrial natriuretic peptide and mortality in patients with community-acquired pneumonia: results from the german competence network CAPNETZ. Respir Med. 2014;108(11):1696–705. doi:10.1016/j.rmed.2014.09.014.CrossRefPubMed Kruger S, Ewig S, Giersdorf S, Hartmann O, Frechen D, Rohde G, et al. Dysnatremia, vasopressin, atrial natriuretic peptide and mortality in patients with community-acquired pneumonia: results from the german competence network CAPNETZ. Respir Med. 2014;108(11):1696–705. doi:10.​1016/​j.​rmed.​2014.​09.​014.CrossRefPubMed
38.
go back to reference Castellano GD, Sallustio C, Montinaro F, Zanichelli V, Bonanni A, Suffritti E, Gesualdo C, Cicardi LM, editors. Modulation of adrenomedullin and plaur genes in the patho-genesis of angioedema due to inherited C1 inhibitor deficiency. Molecular Immunology; 2015. Castellano GD, Sallustio C, Montinaro F, Zanichelli V, Bonanni A, Suffritti E, Gesualdo C, Cicardi LM, editors. Modulation of adrenomedullin and plaur genes in the patho-genesis of angioedema due to inherited C1 inhibitor deficiency. Molecular Immunology; 2015.
39.
go back to reference Dong F, Zhang X, Wold LE, Ren Q, Zhang Z, Ren J. Endothelin-1 enhances oxidative stress, cell proliferation and reduces apoptosis in human umbilical vein endothelial cells: role of ETB receptor, NADPH oxidase and caveolin-1. Br J Pharmacol. 2005;145(3):323–33. doi:10.1038/sj.bjp.0706193.PubMedCentralCrossRefPubMed Dong F, Zhang X, Wold LE, Ren Q, Zhang Z, Ren J. Endothelin-1 enhances oxidative stress, cell proliferation and reduces apoptosis in human umbilical vein endothelial cells: role of ETB receptor, NADPH oxidase and caveolin-1. Br J Pharmacol. 2005;145(3):323–33. doi:10.​1038/​sj.​bjp.​0706193.PubMedCentralCrossRefPubMed
41.
go back to reference Shichiri M, Kato H, Marumo F, Hirata Y. Endothelin-1 as an autocrine/paracrine apoptosis survival factor for endothelial cells. Hypertension. 1997;30(5):1198–203.CrossRefPubMed Shichiri M, Kato H, Marumo F, Hirata Y. Endothelin-1 as an autocrine/paracrine apoptosis survival factor for endothelial cells. Hypertension. 1997;30(5):1198–203.CrossRefPubMed
42.
go back to reference Balakrishnan SM, Gopalakrishnan V, McNeill JR. Endothelin contributes to the hemodynamic effects of vasopressin in spontaneous hypertension. Eur J Pharmacol. 1997;334(1):55–60.CrossRefPubMed Balakrishnan SM, Gopalakrishnan V, McNeill JR. Endothelin contributes to the hemodynamic effects of vasopressin in spontaneous hypertension. Eur J Pharmacol. 1997;334(1):55–60.CrossRefPubMed
Metadata
Title
Novel Vasoregulatory Aspects of Hereditary Angioedema: the Role of Arginine Vasopressin, Adrenomedullin and Endothelin-1
Authors
Erika Kajdácsi
Péter K. Jani
Dorottya Csuka
Lilian Varga
Zoltán Prohászka
Henriette Farkas
László Cervenak
Publication date
01-02-2016
Publisher
Springer US
Published in
Journal of Clinical Immunology / Issue 2/2016
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-016-0239-8

Other articles of this Issue 2/2016

Journal of Clinical Immunology 2/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.